Victoria Galan
Toledo, CM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.
Journal: Clinical drug investigation
Published: September 17, 2024
A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression.
Journal: Frontiers in immunology
Published: February 09, 2024
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
Journal: Acta neuropathologica
Published: January 05, 2023
Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis.
Journal: Neurologia
Published: December 23, 2020
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
Journal: Journal of neurology
Published: February 11, 2020
Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients.
Journal: European journal of immunology
Published: September 26, 2019
Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort.
Journal: European journal of clinical investigation
Published: July 06, 2016
Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
Journal: European journal of neurology
Published: March 09, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026